leisure time -WSS

leisure time

author：hotspot 2025-08-20 09:42:23 - browse：21

UCB website -- health policy coverage from STAT — Adobe

WASHINGTON — UCB left BIO at the end of 2023, the second major member company to exit after Pfizer pulled out as well.

UCB, headquartered in Belgium, decided not to renew its BIO membership after a routine evaluation of its engagement in trade associations, said company spokesperson Erica Puntel.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

Pfizer, whose departure STAT reported first, was listed on BIO’s website as a sponsor at one of the group’s highest levels. Pfizer bought Global Blood Therapeutics, which current BIO Board Chair Ted Love led to the approval of a drug to treat sickle cell disease, in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： A virus, fished out of a lake, may have saved a man’s life

WSS

Bristol 'take

Paxlovid rebound happens. Why and to whom are still a mystery

Stroke deaths set to near 10 million globally by 2050

Failure, not just success, should guide future doctors

Trump used to be more articulate. What could explain the change?

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

knowledge

leisure time

Sign up for D.C. Diagnosis

knowledge

Dobbs anniversary: the lost opportunity of abortion as health care

Sweden knocks USA out of World Cup in penalty kicks

As demand for Covid shots wanes, Moderna seeks its next success

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Walensky prepares to leave CDC — and Congress — behind

Histogen: Failed biotech offers rare public look inside

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Analysis of telehealth claims data suggest service duplication

Apple is now the first public company to be valued at $3 trillion

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Wikipedia

Chemotherapy drug shortage eases slightly but still widespread

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Sweden knocks USA out of World Cup in penalty kicks

3 questions for the future of Biden's cancer moonshot

The future of health care in the House

What to expect at HLTH 2023, the health care industry conference

entertainment

knowledge

hotspot

leisure time